FDA issued a Warning Letter to Lupin Limited on 5/7/2009 for a later inspection.
483 Lupin Feb 2000

483 Lupin Feb 2000

Charles Ahn FDA$595.00 - Available Now

FDA investigators audited the Lupin - Mandideep, India facility and issued inspectional observations (via FDA 483) on 24 Feb 2000.

Product details

  • Category: Human Drugs
  • Inspection end: 24 Feb 2000
  • Location: Mandideep, India
  • FEI: 3002807511
Add To Cart